-
1 Comment
Hubei Jumpcan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 15.1% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Hubei Jumpcan Pharmaceutical Co., Ltd's total revenue sank by 7.9% to $1B since the same quarter in the previous year.
Its net income has dropped by 19.6% to $275M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.1% to $132M since the same quarter in the previous year.
Based on the above factors, Hubei Jumpcan Pharmaceutical Co., Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE0000018X6 |
| Dividend Yield | 7.8% |
|---|---|
| Market Cap | 25B |
| PE Ratio | 14.8 |
| Target Price | 52.36 |
| Beta | 0.11 |
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, hemostasis, gynecology, pneumology, gastroenterology, and geriatrics. The company is headquartered in Taixing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600566.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
